Episode 9: Receptor Selective (2nd Generation) Antidepressants

episode

This Is Your Brain On Drugs Psychiatry Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-22-2026 7PM EDT 4 min · 22 Sep 2026 · NPR News Now

US-Iran Talks on Sidelines of UN Summit, Chipmakers Rally, More 7 min · 22 Sep 2026 · Bloomberg News Now

7PM ET 09/22/2026 Newscast 3 min · 22 Sep 2026 · Fox News Hourly Update

Dentists Are Making Millions From This Lie - Dr. Ellie Phillips EXPOSES the dental industry 1h 5m · 22 Sep 2026 · Redacted News

Inside Big Brother: Nasty Nick (Ep 1) 39 min · 22 Sep 2026 · The Rest Is Entertainment

Jon Ronson on Conspiracy, Masculinity and Writing 1h 46m · 22 Sep 2026 · The Blindboy Podcast

Report any issue

Source

Recorded23 Oct 2024

Publisherfeeds.podcastle.ai

Handlerec:12104165

Show notes

Let's get to know the second generation antidepressants, otherwise known as receptor selective antidepressants. These antidepressants started in the 1980s with the newest one coming out just last year. They tend to only mingle with one or two receptors and have much lower adverse effects than the MAOis and TCAs. They are what most of us think about when we think about antidepressants. In this episode we do an overview of them from FDA approved uses to off label uses. And at the end a little bonus content. I talk about contraindications of the TCAs which I missed in the last episode.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in